By Benjamin Chiou
Date: Tuesday 14 Oct 2025
(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.
Transaction in Own Shares | 17-Oct-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 16-Oct-2025 | 15:30 | RNS |
Transaction in Own Shares | 16-Oct-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 15-Oct-2025 | 15:30 | RNS |
Transaction in Own Shares | 15-Oct-2025 | 07:00 | RNS |
GSK boss Emma Walmsley to receive benefits for y... | 06-Oct-2025 | Times |
GlaxoSmithKline scraps sale of old drugs | 05-Dec-2014 | Telegraph |
Glaxo sharpens axe to save £1bn as insurers and ... | 01-Dec-2014 | The Independent |
GSK to cut hundreds of US jobs | 01-Dec-2014 | Telegraph |
Ebola vaccine trials 'encouraging', says GSK | 27-Nov-2014 | Telegraph |
Questor :GlaxoSmithKline | 16-Apr-2014 | Telegraph |
Questor:GlaxoSmithKline | 06-Oct-2011 | Telegraph |
Questor:GlaxoSmithKline | 11-Aug-2011 | Telegraph |
Questor tip: GlaxoSmithKline | 28-Jul-2011 | Telegraph |
Investment Column: GlaxoSmithKline | 27-Jul-2011 | The Independent |
Currency | UK Pounds |
Share Price | 1,625.00p |
Change Today | -9.00p |
% Change | -0.55 % |
52 Week High | 1,671.50 |
52 Week Low | 1,264.00 |
Volume | 7,130,599 |
Shares Issued | 4,063.72m |
Market Cap | £66,035m |
RiskGrade | 129 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 3 |
Buy | 3 |
Neutral | 14 |
Sell | 3 |
Strong Sell | 0 |
Total | 23 |
Latest | Previous | |
---|---|---|
Q2 | Q1 | |
Ex-Div | 14-Aug-25 | 15-May-25 |
Paid | 09-Oct-25 | 10-Jul-25 |
Amount | 16.00p | 16.00p |
Time | Volume / Share Price |
14:52 | 0 @ 1,617.50p |
16:38 | 1,286 @ 1,625.00p |
16:38 | 4,562 @ 1,625.00p |
16:38 | 6,383 @ 1,625.00p |
16:38 | 208 @ 1,625.00p |
You are here: research